SBFM Insider Trading Activity and SEC Form 4 Filings
SBFM insider trading summary
No open-market insider purchases or sales of Sunshine Biopharma, Inc (SBFM) have been reported on SEC Form 4 in the past 12 months.
Latest SBFM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 4, 2024 | Steve N. Slilaty | Chief Executive Officer | Buy | $10K (100,000 @ $0.10) |
| Feb 8, 2024 | Steve N. Slilaty | Chief Executive Officer | Buy | $2K (20,000 @ $0.10) |
| Nov 30, 2022 | Camille Sebaaly | CFO/Secretary | Buy | $23K (30,000 @ $0.76) |
| Jun 3, 2022 | Camille Sebaaly | CFO/Secretary | Buy | $31K (25,000 @ $1.22) |
| Apr 12, 2016 | Steve N. Slilaty | Chief Executive Officer | Buy | $50K (253,082 @ $0.20) |
| May 27, 2015 | Steve N. Slilaty | Chief Executive Officer | Buy | $50K (500,000 @ $0.10) |
| Sep 4, 2012 | Steve N. Slilaty | Chief Executive Officer | Sell | $130K (2,591,500 @ $0.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.